Immunological differences between colorectal cancer and normal mucosa uncover a prognostically relevant immune cell profile

T cells in colorectal cancer (CRC) are associated with improved survival. However, checkpoint immunotherapies antagonizing the suppression of these cells are ineffective in the great majority of patients. To better understand the immune cell regulation in CRC, we compared tumor-associated T lymphocy...

Descripción completa

Detalles Bibliográficos
Autores principales: Strasser, Katharina, Birnleitner, Hanna, Beer, Andrea, Pils, Dietmar, Gerner, Marlene C., Schmetterer, Klaus G., Bachleitner-Hofmann, Thomas, Stift, Anton, Bergmann, Michael, Oehler, Rudolf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343804/
https://www.ncbi.nlm.nih.gov/pubmed/30713795
http://dx.doi.org/10.1080/2162402X.2018.1537693

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343804/
https://www.ncbi.nlm.nih.gov/pubmed/30713795
http://dx.doi.org/10.1080/2162402X.2018.1537693

Ejemplares similares